Stay updated on AT1001 Long-term Safety Study in Fabry Disease Clinical Trial
Sign up to get notified when there's something new on the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page.

Latest updates to the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page
- Check4 days agoChange DetectedLocations section now lists Georgia, New York, and Texas under Locations. The HHS Vulnerability Disclosure link was removed and the revision tag updated from v3.3.2 to v3.3.3.SummaryDifference0.5%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.2.0 removed and v3.3.2 added; no core content or trial details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedThe government funding status notice at the top of the ClinicalTrials.gov page was removed.SummaryDifference0.4%

- Check54 days agoChange DetectedMinor formatting adjustments and wording clarifications in the Study Details page; no substantive changes to eligibility criteria, outcomes, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference4%

- Check90 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to AT1001 Long-term Safety Study in Fabry Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page.